Company
Company
Our Mission
Leadership
Pipeline
Technology
Quantum Engine™
GTailor™
Quantum Nufect™
Quantum pBac™
iCellar™
qCART™
Protein / Target Hunter
Clinical trial
Partnership
Media
Events & Presentations
Publications
Careers
Contact Us
English
繁體中文
✕
EVENTS & PRESENTATIONS
Events
Our Founder/CEO/CSO, Sareina Wu, and our Director of Scientific Communication, Marcus Calkins, will present our work as invited speakers at the Advanced Therapies in Boston, US. (November 4-5, 2025)
Read more
GF-CART01 Clinical Milestone & GF-CART03 Solid Tumor Innovation Unveiled
Read more
GenomeFrontier’s GF-CART01 Achieves Complete Response in First Patient of Phase I Trial, Demonstrating the Potential of the qCART™ platform
Read more
GenomeFrontier Showcases Virus-Free CAR-T Platform at 2025 ATC, Paving the Way for the Future of Gene and Cell Therapy
Read more
GenomeFrontier Awarded $100,000 G-Rex® Grant to Advance Non-Viral CAR T Cell Therapy, GF-CART01
Read more
1
2
3
...
8
Next page
